|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|PE Ratio (TTM)||17.03|
|Forward Dividend & Yield||0.76 (2.18%)|
|1y Target Est||N/A|
SINGAPORE, May 16, 2018 /PRNewswire/ -- AIA Singapore and Medix today announced that they have entered into an exclusive partnership to provide Personal Medical Case Management Services (PMCM) to customers. This adds to AIA Singapore's comprehensive healthcare proposition, which is focused on providing quality healthcare and the best customer experience, enabling customers to receive the best possible treatment and personalised ongoing support throughout their medical journey when they face serious medical conditions.
The easing of foreign ownership rules in the Chinese insurance industry will help both foreign and domestic players.
Announcement: Moody's comments on CBA's sale of its life insurance businesses. Global Credit Research- 21 Sep 2017. Sydney, September 21, 2017-- Moody's Investors Service says that Commonwealth Bank of ...
Rating Action: Moody's affirms senior debt ratings of AIA Group Limited at A2 with a stable outlook. Global Credit Research- 22 Sep 2017. Hong Kong, September 22, 2017-- Moody's Investors Service has affirmed ...